[1] Mendelson CL.Disorders of the heartbeat during pregnancy[J]. Am J Obstet Gynecol,1956,72:1268. [2] McCans JL, Wenger NK. Problems in management of the pregnant patient with rheumatic heart disease and valve prosthesis[J].South Med J,1976,69:1007. [3] Bates SM, Greer IA, Middeldorp S, V eenstra DL, Prabulos AM, V andvik PO,American College of Chest Physicians. VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9thed: American College of Chest Physicians Evidence-Based Clinical PracticeGuidelines,2012,141:691-736. [4] European Society of Gynecology (ESG), Association for European Paediatric Cardiology (AEPC), German Society for Gender Medicine (DGesGM), et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J,2011, 32:3147 [5] Jaeggi ET, Carvalho JS, De Groot E, Api O, Clur SA, Rammeloo L, McCrindle BW,Ryan G, Manlhiot C, Blom NA. Comparison of transplacental treatment of fetalsupraventricular tachyarrhythmias with digoxin, flecainide, and sotalol: resultsof a nonrandomized multicenter study[J]. Circulation,2011,124:1747-1754 [6] DeSilva RA, Graboys TB, Podrid PJ, Lown B. Cardioversion and defibrillation[J]. Am Heart J,1980,100:881 [7] Barnes EJ, Eben F, Patterson D.Direct current cardioversion during pregnancy should be performed with facilities available for fetal monitoring and emergency caesarean section[J]. BJOG,2002,109:1406. [8] Magee LA, Duley L. Oral beta-blockers for mild to moderate hypertension duringpregnancy[J]. Cochrane Database Syst Rev,2003,3:CD002863. |